Table.
Baseline characteristics, combined and by country, for the exposed set and the per-protocol set
| Control | R012-20 | R012-14 | Fx012-14 | Fx017-20 | ||
|---|---|---|---|---|---|---|
| Exposed set | ||||||
| Participant count | 293 | 298 | 294 | 304 | 311 | |
| Ghana | 147 (50%) | 153 (51%) | 151 (51%) | 148 (49%) | 151 (49%) | |
| Kenya | 146 (50%) | 145 (49%) | 143 (49%) | 156 (51%) | 160 (51%) | |
| Male participants | 141 (48%) | 179 (60%) | 140 (48%) | 132 (43%) | 148 (48%) | |
| Ghana | 65/141 (46%) | 93/179 (52%) | 68/140 (49%) | 64/132 (48%) | 76/148 (51%) | |
| Kenya | 76/141 (54%) | 86/179 (48%) | 72/140 (51%) | 68/132 (52%) | 72/148 (49%) | |
| Female participants | 152 (52%) | 119 (40%) | 154 (52%) | 172 (57%) | 163 (52%) | |
| Ghana | 82/152 (54%) | 60/119 (50%) | 83/154 (54%) | 84/172 (49%) | 75/163 (46%) | |
| Kenya | 70/152 (46%) | 59/119 (50%) | 71/154 (46%) | 88/172 (51%) | 88/163 (54%) | |
| Age at first vaccination, months | 10·5 (3·9) | 10·2 (3·9) | 10·3 (3·8) | 10·5 (4·0) | 10·2 (3·8) | |
| Ghana | 10·4 (4·0) | 9·7 (3·9) | 10·4 (4·0) | 10·1 (4·0) | 10·2 (4·1) | |
| Kenya | 10·7 (3·8) | 10·7 (3·7) | 10·1 (3·6) | 10·9 (4·0) | 10·2 (3·6) | |
| BMI, kg/m2 | 16·5 (1·4) | 16·9 (1·6) | 16·7 (1·6) | 16·9 (1·6) | 16·8 (1·8) | |
| Ghana | 16·1 (1·2) | 16·4 (1·4) | 16·2 (1·4) | 16·4 (1·4) | 16·2 (1·6) | |
| Kenya | 17·0 (1·5) | 17·4 (1·6) | 17·2 (1·7) | 17·3 (1·7) | 17·3 (1·7) | |
| Haemoglobin, g/dL | 10·3 (1·1) | 10·1 (1·1) | 10·3 (1·1) | 10·4 (1·1) | 10·3 (1·1) | |
| Ghana | 10·7 (1·0) | 10·5 (1·1) | 10·7 (1·0) | 10·7 (1·1) | 10·6 (1·0) | |
| Kenya | 9·9 (1·2) | 9·7 (1·1) | 9·9 (1·1) | 10·1 (1·1) | 10·0 (1·0) | |
| Height, cm | 71·2 (5·3) | 70·7 (5·3) | 71·0 (5·3) | 70·8 (5·2) | 70·7 (5·1) | |
| Ghana | 71·8 (5·4) | 70·4 (5·6) | 71·4 (5·3) | 71·0 (5·6) | 71·4 (5·6) | |
| Kenya | 70·7 (5·1) | 71 (5·0) | 70·7 (5·2) | 70·6 (4·7) | 70·1 (4·5) | |
| Weight, kg | 8·4 (1·3) | 8·5 (1·3) | 8·5 (1·5) | 8·5 (1·4) | 8·4 (1·4) | |
| Ghana | 8·3 (1·4) | 8·2 (1·4) | 8·3 (1·4) | 8·3 (1·4) | 8·3 (1·6) | |
| Kenya | 8·5 (1·3) | 8·8 (1·3) | 8·7 (1·6) | 8·6 (1·3) | 8·5 (1·2) | |
| Per-protocol set | ||||||
| Participant count | 265 | 259 | 264 | 271 | 273 | |
| Ghana | 141 (53%) | 134 (52%) | 135 (51%) | 136 (50%) | 141 (52%) | |
| Kenya | 124 (47%) | 125 (48%) | 129 (49%) | 135 (50%) | 132 (48%) | |
| Male participants | 128 (48%) | 151 (58%) | 128 (48%) | 115 (42%) | 131 (48%) | |
| Ghana | 60/128 (47%) | 77/151 (51%) | 64/128 (50%) | 58/115 (50%) | 68/131 (52%) | |
| Kenya | 68/128 (53%) | 74/151 (49%) | 64/128 (50%) | 57/115 (50%) | 63/131 (48%) | |
| Female participants | 137 (52%) | 108 (42%) | 136 (52%) | 156 (58%) | 142 (52%) | |
| Ghana | 81/137 (59%) | 57/108 (53%) | 71/136 (52%) | 78/156 (50%) | 73/142 (51%) | |
| Kenya | 56/137 (41%) | 51/108 (47%) | 65/136 (48%) | 78/156 (50%) | 69/142 (49%) | |
| Age at first vaccination, months | 10·5 (3·8) | 10·3 (3·9) | 10·2 (3·8) | 10·3 (3·9) | 10·1 (3·9) | |
| Ghana | 10·3 (3·9) | 9·7 (4·0) | 10·3 (4·0) | 9·8 (3·9) | 10·2 (4·1) | |
| Kenya | 10·8 (3·6) | 10·9 (3·7) | 10·1 (3·5) | 10·8 (3·9) | 10·1 (3·5) | |
| BMI, kg/m2 | 16·5 (1·4) | 16·8 (1·5) | 16·8 (1·6) | 16·8 (1·6) | 16·7 (1·7) | |
| Ghana | 16·1 (1·2) | 16·4 (1·3) | 16·3 (1·4) | 16·4 (1·4) | 16·2 (1·6) | |
| Kenya | 16·9 (1·5) | 17·2 (1·6) | 17·3 (1·7) | 17·2 (1·6) | 17·3 (1·7) | |
| Haemoglobin, g/dL | 10·3 (1·1) | 10·1 (1·1) | 10·3 (1·1) | 10·4 (1·1) | 10·3 (1·1) | |
| Ghana | 10·7 (1·0) | 10·5 (1·0) | 10·7 (0·9) | 10·7 (1·0) | 10·6 (1·0) | |
| Kenya | 9·9 (1·1) | 9·7 (1·1) | 9·9 (1·1) | 10·2 (1·1) | 10·0 (1·1) | |
| Height, cm | 71·4 (5·1) | 70·8 (5·4) | 70·9 (5·1) | 70·6 (5·1) | 70·6 (5·1) | |
| Ghana | 71·8 (5·4) | 70·4 (5·7) | 71·3 (5·2) | 70·7 (5·5) | 71·3 (5·6) | |
| Kenya | 70·9 (4·8) | 71·2 (5·0) | 70·6 (5·0) | 70·5 (4·7) | 69·9 (4·5) | |
| Weight, kg | 8·4 (1·3) | 8·4 (1·4) | 8·5 (1·5) | 8·4 (1·3) | 8·3 (1·4) | |
| Ghana | 8·3 (1·4) | 8·2 (1·4) | 8·3 (1·4) | 8·2 (1·4) | 8·3 (1·6) | |
| Kenya | 8·5 (1·3) | 8·7 (1·3) | 8·6 (1·6) | 8·6 (1·2) | 8·4 (1·2) | |
Data are n (%), n/N (%), or mean (SD).